0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology

Buy Now

Lung Inflammation in Health and Disease, Volume I (Paperback, 1st ed. 2021) Loot Price: R7,417
Discovery Miles 74 170
Lung Inflammation in Health and Disease, Volume I (Paperback, 1st ed. 2021): Yong-Xiao Wang

Lung Inflammation in Health and Disease, Volume I (Paperback, 1st ed. 2021)

Yong-Xiao Wang

Series: Advances in Experimental Medicine and Biology, 1303

 (sign in to rate)
Loot Price R7,417 Discovery Miles 74 170 | Repayment Terms: R695 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Respiratory diseases are leading causes of death and disability globally, with about 65 million people suffering from COPD, and 334 million from asthma, the most common chronic disease. Each year, tens of millions of people develop and can die from from respiratory infections such as pneumonia and TB. Systemic inflammation may induce and exacerbate local inflammatory diseases in the lungs, and local inflammation can in turn cause systemic inflammation. There is increasing evidence of the coexistence of systemic and local inflammation in patients suffering from asthma, COPD, and other lung diseases, and the co-morbidity of two or more local inflammatory diseases often occurs. For example, rheumatoid arthritis frequently occurs together with, and promotes the development of, pulmonary hypertension. This co-morbidity significantly impacts quality of life, and can result in death for those affected. Current treatment options for lung disease are neither effective, nor condition-specific; there is a desperate need for novel therapeutics in the field. Additionally, the molecular and physiological significance of most major lung diseases is not well understood, which further impedes development of new treatments, especially in the case of coexistent lung diseases with other inflammatory diseases. Great progress has been made in recent years in many areas of the field, particularly in understanding the molecular geneses, regulatory mechanisms, signalling pathways, and cellular processes within lung disease, as well as basic and clinical technology, drug discovery, diagnoses, treatment options, and predictive prognoses. This is the first text to aggregate these developments. In two comprehensive volumes, experts from all over the world present state-of-the-art advances in the study of lung inflammation in health and disease. Contributing authors cover well-known as well as emerging topics in basic, translational, and clinical research, with the aim of providing researchers, clinicians, professionals, and students with new perspectives and concepts. The editors hope these books will also help to direct future research in lung disease and other inflammatory diseases, and result in the development of novel therapeutics.

General

Imprint: Springer Nature Switzerland AG
Country of origin: Switzerland
Series: Advances in Experimental Medicine and Biology, 1303
Release date: April 2022
First published: 2021
Editors: Yong-Xiao Wang
Dimensions: 254 x 178mm (L x W)
Format: Paperback
Pages: 409
Edition: 1st ed. 2021
ISBN-13: 978-3-03-063048-5
Categories: Books > Medicine > Clinical & internal medicine > Respiratory medicine
Books > Medicine > General issues > Medical equipment & techniques > Medical research
Books > Medicine > Pre-clinical medicine: basic sciences > Physiology > General
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology > General
LSN: 3-03-063048-X
Barcode: 9783030630485

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners